Lumbar Puncture and Syphilis Outcome
NCT02031146 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 231
Last updated 2021-05-25
Summary
Treponema pallidum, the bacterium that causes syphilis, invades the central nervous system in about 40% of patients with syphilis. This happens early after infection. Patients with neuroinvasion are at risk of developing serious neurological complications, including vision or hearing loss, stroke and dementia. Because neuroinvasion can happen without symptoms, the only way to identify it is by performing a lumbar puncture (LP) to examine cerebrospinal fluid (CSF).The overall hypothesis to be tested in this study is that a strategy of immediate LP, followed by therapy based on CSF evaluation, results in better serological and functional outcomes in patients with syphilis who are at high risk for neuroinvasion.
Conditions
- Syphilis
Interventions
- PROCEDURE
-
Lumbar puncture
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH - lead OTHER
Principal Investigators
-
Christina M Marra, MD · University of Washington
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- United States
Study Locations
More Related Trials
-
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
NCT03047980 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program
NCT05368038 ·Status: ENROLLING_BY_INVITATION
-
Efficacy and Safety of Sirolimus to Vascular Anomalies
NCT03583307 ·Status: COMPLETED ·Phase: NA
-
Weekly Sirolimus Therapy
NCT04861064 ·Status: RECRUITING ·Phase: PHASE2
-
The Therapeutic Effect of Thalidomide in Syringomyelia
NCT06268093 ·Status: RECRUITING ·Phase: PHASE2
-
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
NCT06999954 ·Status: RECRUITING
-
Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)
NCT03614663 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prenatal Screening For Smith-Lemli-Opitz Syndrome
NCT00070850 ·Status: COMPLETED
-
A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications
NCT02012114 ·Status: COMPLETED ·Phase: NA
-
A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy
NCT04998812 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers
NCT02837705 ·Status: COMPLETED
-
A Study of Sepiapterin in Participants With Phenylketonuria (PKU)
NCT06302348 ·Status: RECRUITING ·Phase: PHASE3
-
Decisional Capacity and Informed Consent in Fragile X Syndrome
NCT02465931 ·Status: COMPLETED ·Phase: NA
-
Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS
NCT03802799 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA
NCT05334576 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of Cannabidiol in Children, Adolescents, and Young Adults With Fragile X Syndrome
NCT04977986 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).
NCT03790137 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease
NCT03621826 ·Status: COMPLETED
-
Sirolimus for Leigh Syndrome
NCT06843811 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
An Open Label Extension Study in Subjects With Fragile X Syndrome
NCT01555333 ·Status: TERMINATED ·Phase: PHASE3
-
Baker Gordon Syndrome Natural History Study
NCT06399952 ·Status: RECRUITING
-
Riluzole in Fragile X Syndrome
NCT00895752 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Controlled Study of Donepezil in Fragile X Syndrome
NCT01120626 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy
NCT03771898 ·Status: COMPLETED ·Phase: PHASE2
-
Pyruvate Kinase Deficiency Global Longitudinal Registry Substudy of Protocol AG348-C-008
NCT04995315 ·Status: COMPLETED